Company

Mantle Therapeutics

Rocket Ship Rating

Rocket Ship Rating: 75 out of 100

Biotech & therapeutics
AI native

Business model: B2B

mantletherapeutics.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Mantle Therapeutics is developing treatments for rare neurological diseases by repurposing already approved drugs using AI-driven target assessment, with an initial focus on Friedreich’s Ataxia (FA)

Investor VC firms in this preview

AIN Ventures

VC firm
Company
Partner

VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.

Mantle Therapeutics

About

Relationship map preview

Relationship map preview